CTLA4
Clinical trials for CTLA4 explained in plain language.
Never miss a new study
Get alerted when new CTLA4 trials appear
Sign up with your email to follow new studies for CTLA4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double-Target immunotherapy added to standard care for aggressive cervical cancer
Disease control By invitation onlyResearchers are testing whether adding cadonilimab, an immunotherapy drug, to chemotherapy before and after standard chemoradiation can help women with high-risk, locally advanced cervical cancer. The trial enrolls 20 women who have not received prior treatment. Participants rece…
Matched conditions: CTLA4
Sponsor: Hubei Cancer Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Spinal injection of dual immunotherapy plus chemotherapy targets cancer spread to brain lining
Disease control OngoingThis phase I/II trial tests a combination of two drugs given directly into the spinal fluid for people with leptomeningeal metastasis, a condition where cancer spreads to the membranes covering the brain and spinal cord. The drugs are QL1706, a bispecific antibody that blocks two…
Matched conditions: CTLA4
Phase 1/2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC